This inventor holds 2 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Opko Biologics Ltd., Opko Biologistics Ltd.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Laura Moschcovich: Innovator in Coagulation Factors
Introduction
Laura Moschcovich is a prominent inventor based in Givat Shmuel, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of long-acting coagulation factors. Her innovative work has the potential to improve treatment options for patients with coagulation disorders.
Latest Patents
Laura holds a patent for "Long-acting coagulation factors and methods of producing same." This patent discloses polypeptides that comprise at least one carboxy-terminal peptide (CTP) of chorionic gonadotropin attached to the carboxy terminus, but not to the amino terminus of a coagulation factor. Additionally, it includes polynucleotides encoding these polypeptides, as well as pharmaceutical compositions and formulations that utilize them. The methods of using and producing these innovative compounds are also detailed in her patent.
Career Highlights
Laura is currently associated with Opko Biologics Ltd., where she continues to advance her research and development efforts. Her work is characterized by a commitment to enhancing therapeutic options in the medical field, particularly for those suffering from blood-related disorders.
Collaborations
Laura collaborates with Oren Hershkovitz, contributing to the innovative environment at Opko Biologics Ltd. Their partnership exemplifies the collaborative spirit that drives advancements in biotechnology.
Conclusion
Laura Moschcovich is a trailblazer in the field of coagulation factors, with her patent representing a significant advancement in medical science. Her contributions are poised to make a lasting impact on patient care and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile